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The nucleocapsid (NC) protein from HIV-1 contains two zinc-fingers, both of which are necessary for virus replication. This is the first in-
depth study that presents the effects of nucleocapsid zinc-finger substitutions on the kinetics of reverse transcription and integration. Over a 72-h
time-course of infection, the quantities of viral DNA (vDNA) observed with viruses containing either the nucleocapsid His23Cys or His44Cys
mutations were significantly lower than those observed in infections with virus containing wild-type NC. In addition, the kinetics of vDNA
formation and loss were significantly different from wild-type. The kinetic profiles observed indicated reduced vDNA stability, as well as defects
in reverse transcription and integration. Overall, the defect in integration was much more pronounced than the reverse transcription defects. This
suggests that the principal reason for the replication defectiveness of these mutant viruses is impairment of integration, and thus demonstrates the
critical importance of NC in HIV-1 infection.
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Nucleocapsid (NC) of HIV-1 functions during many steps
of the virus life cycle, and is critically important for virus
replication (Buckman et al., 2003; Darlix et al., 2002). NC is
highly basic in amino acid composition and contains two zinc-
finger motifs of the sequence –Cys–X2–Cys–X4–His–X4–
Cys–, which are necessary for many of its activities. Because
NC functions throughout the viral life cycle, in-depth
mutational analysis of NC in infection processes has mainly
been limited to studies on virion assembly and genomic RNA
(gRNA) packaging. Several in vivo studies have been
performed using mutant viruses to examine NC's roles in⁎ Corresponding author. Fax: +1 301 846 7119.
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doi:10.1016/j.virol.2006.05.014reverse transcription and integration (Buckman et al., 2003;
Gorelick et al., 1999a; Tanchou et al., 1998). However, the
majority of studies have been performed using in vitro systems
that assay specific NC functions that are thought to occur during
early infection events, including reverse transcription (Drum-
mond et al., 1997; Guo et al., 2000; Ji et al., 1996; Klasens et al.,
1999; Wu et al., 1996), viral DNA (vDNA) protection (Lapadat-
Tapolsky et al., 1993; Tanchou et al., 1995), and integration
(Carteau et al., 1999; Gao et al., 2003).
Based on these in vitro experiments, it is clear that a major
function of NC is as a nucleic acid chaperone; that is, NC assists
nucleic acids in obtaining the most thermodynamically stable
annealed structures (Levin et al., 2005; Rein et al., 1998). During
HIV-1 infections, NC melts nucleic acid secondary structures
that would otherwise result in pausing or premature termination
of reverse transcription, which has been observed in numerous in
vitro studies (Drummond et al., 1997; Ji et al., 1996; Klasens
et al., 1999; Wu et al., 1996). The two zinc-fingers have been
shown to be important for this chaperone activity, as mutations
eliminating either finger abrogate this function (Levin et al.,
Table 1
Properties of mutant and wild-type virus particles
Virus gRNA packaging
(% of wild-type levels) a
(−)-Control b 0
NCH23C 74 ± 20
NCH23CIND116N 100 ± 7.6
NCH44C 28 ± 4.3
NCH44CIND116N 25 ± 3.3
IND116N 121 ± 4.9
Wild type 100
a “gRNA (genomic RNA) packaging” is expressed as a percentage of wild-
type levels ± the standard error of the mean. The quantity of viral genomes per
mL of transfection supernatant was divided by the exogenous RT activity (cpm
[3H]-TMP incorporated/mL) of transfection supernatant for each experiment.
The resulting value, quantities of RNA per RT activity, was then divided by the
value calculated for wild-type virus and this ratio was converted to a percentage
(i.e. [mG / mRT] / [wtG / wtRT] × 100, where m = mutant, wt = wild-type,
G = genomic RNA per mL, RT = RT activity per mL). The percentages shown
are means from at least three separate transfection experiments. Genome
quantities were determined as described in Materials and methods.
b “(−)-Control”, transfection of 293T cells with sheared salmon sperm DNA.
42 J.A. Thomas et al. / Virology 353 (2006) 41–512005). A major strength of in vitro systems is that through
careful design, it is possible to demonstrate discrete functions of
NC. However, during an infection, NC functions as part of a
complex comprised of viral and cellular proteins, as well as
membrane and nucleic acid elements.
Early in vivo studies demonstrated that mutations that
disrupt the ability of NC to bind zinc cause replication-defective
phenotypes, but in many instances the reason was partially
attributed to significant gRNA packaging defects (Aldovini and
Young, 1990; Dorfman et al., 1994; Gorelick et al., 1990, 1993).
To examine the nature of NC's true role in early infection
events, it was imperative that nucleocapsid mutant viruses
package significant levels of gRNA. To this end, a series of
mutants was generated in which key cysteine or histidine
residues were replaced by histidine or cysteine, respectively
(Gorelick et al., 1999b). Although these mutations still enabled
NC to bind zinc, many of them produced virions that packaged
their gRNA poorly. Generally, alterations to the carboxyl-
terminal zinc-finger were better tolerated than the equivalent
alterations in the amino-terminal finger. Two of the zinc-finger
mutants, His23Cys (NCH23C) and His44Cys (NCH44C), do
package significant levels of gRNA and produce wild-type
levels of virus particles, but are, nevertheless, replication-
defective (Gorelick et al., 1999b). These two His-to-Cys zinc-
finger mutants have been tested in numerous specific in vitro
assays to measure enhancement of tRNA annealing (Rong et al.,
1998, 2001), initiation of reverse transcription (Rong et al.,
1998, 2001), strand transfer activity (Guo et al., 2002; Hsu et al.,
2000), and integration (Carteau et al., 1999). The NCH23C
mutation does appear to alter the nature of tRNA annealing,
thereby reducing reverse transcription initiation (Rong et al.,
2001). Both NCH23C and NCH44C mutants (i) decrease the
efficiency of strand transfer and (ii) impair NC's ability to
promote coupled integration. In all these in vitro assays, the
NCH44C mutant is less defective than NCH23C, which correlated
with observations that, in NCH44C mutant virus infections,
occasional reversions to a wild-type genotype were obtained,
while none occurred with the NCH23C infections (Gorelick et al.,
1999b).
An initial analysis of vDNA synthesis upon infection of
permissive cells with the NCH23C or NCH44C mutant viruses was
performed to ascertain if these mutations affected nucleic acid
chaperone functions in cell-based assays. At 24 h postinfection
with either the NCH23C or NCH44C mutant virus, quantities of
vDNAwere considerably lower than those observed with wild-
type virus. This suggested the presence of defects in reverse
transcription and reduced vDNA stability, but it was unclear
how the infection proceeded to this point. In addition, sequence
analyses of 2-LTR circle junctions indicated a severe defect in
integration for both the NCH23C and NCH44C mutant viruses
(Buckman et al., 2003). A number of questions remained
regarding (i) the rate of formation or degradation of vDNA
intermediates in the mutant infections, (ii) whether strand
transfer efficiency was reduced, and (iii) the magnitude of the
integration defect.
The present study extends our previous report to provide an
in-depth analysis of the impact of the NCH23C and the NCH44Cmutations upon early infection. Quantities of vDNA were
measured over a 72-h time-course to provide a kinetic picture of
vDNA synthesis and loss. In addition, a real-time quantitative
Alu-LTR PCR assay (Butler et al., 2001) was implemented to
directly measure quantities of proviruses. This report shows that
alterations in either the amino- or carboxyl-terminal zinc-finger
motifs result in minor reverse transcription defects and
somewhat reduced vDNA stability, but greatly decreased
integration efficiency. The impairment to integration alone
would account for the replication defects observed previously
(Gorelick et al., 1999b).
Results
Expression of NC mutant viruses
Viruses containing either the NCH23C or the NCH44C
mutation are replication-defective (Gorelick et al., 1999b), so
it was necessary to limit wild-type infections to a single round.
Otherwise, comparison of vDNA quantities between wild-type
and the NCH23C or NCH44C mutant virus infections would be
complicated at all time-points after 12 h when wild-type virus
began re-infecting cells (Butler et al., 2002; Kim et al., 1989).
Pseudotyped viruses were generated by co-transfecting Env(−)
full-length proviral plasmids with a VSV-G expression plasmid
(Burns et al., 1993) into 293T cells.
Because many NC mutations affect gRNA packaging
(Aldovini and Young, 1990; Dorfman et al., 1994; Gorelick et
al., 1990, 1993, 1999b), we examined the ability of the
transfection-generated viruses to package gRNA (Table 1).
Quantities were measured using real-time quantitative RT-PCR
on viral pellets obtained from cell culture supernatants, were
then normalized for equivalent exogenous template-RT activ-
ities, and reported as percent of wild-type gRNA levels (Table
1). In agreement with our previous report (Gorelick et al.,
1999b), the NCH23C mutant showed wild-type levels of gRNA
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(Gorelick et al., 1999b), the NCH44C mutant showed only 25%
wild-type packaging. The reason for this difference is due in
part to different assays used to calculate this ratio. In this study,
RT activity was used to normalize the gRNA levels, whereas
previously, gRNA were normalized to p24CA levels. Although
the amount of gRNA packaged is reduced in the NCH44C
mutant, the levels were sufficient to yield easily detectable
reverse transcription intermediates.
Quantitation of vDNA
The viruses produced were used to infect HOS cells for 4 h,
the cultures were then washed, and at specific time-points
postinfection, total cellular DNAwas isolated. The quantities of
reverse transcription intermediates, 2-LTR circles, and pro-
viruses were measured using real-time quantitative PCR. At 4 h
postinfection, levels of plasmid DNA contamination (based on
the RTD185K/D186L mutant virus controls) were highest (less than
5% of wild-type vDNA levels); these levels decreased
precipitously and by 8 to 12 h postinfection were undetectable.
The reverse transcription intermediates measured were
designed to monitor completion of discrete steps, including
minus-strand strong-stop (R-U5), minus-strand transfer (U3–
U5), late minus-strand synthesis (Gag), and plus-strand transfer
(R-5′UTR) (Buckman et al., 2003). The quantities of R-U5
provide an estimate of total quantities of vDNA, since minus-
strand strong-stop is the first species synthesized. Likewise, R-
5′UTR provides an upper limit for quantities of full-length or
nearly full-length vDNA generated. Integration products were
measured using an Alu-LTR assay similar to that described by
Butler et al. (2001) to determine the levels of proviruses formed.
2-LTR circles were also examined to verify integrationFig. 1. Quantities of vDNA over a time-course of infection. Values for each point wer
(wild-type NC), 4 (NCH23C), or 2 (NCH44C) separate transfection-infection experimen
virus infections. Error bars are specifically not shown on the graphs to reduce unne
(SEM) was typically ∼30%. Symbols are presented at the bottom of the figure. Dot
approximately 100 copies.efficiencies and levels of vDNA completion (see below); they
are a nonproductive endpoint of reverse transcription that are
formed when nuclear enzymes have access to vDNA (Coffin et
al., 1997; Kilzer et al., 2003; Li et al., 2001). In wild-type
infections, circular vDNA consists mainly of species that could
not be integrated (due mainly to truncated LTR ends; Buckman
et al., 2003). However, if either NC mutation causes a defect in
integration, it is possible that increased quantities of circular
species will be present as was observed in infections with the
IND116N mutant of HIV-1 that is defective for integration
through an active site mutation (Buckman et al., 2003;
Engelman et al., 1995). It should be noted that provirus, full-
length linear vDNA, and full-length 2-LTR circles all contain
two target sites for R-U5 and U3–U5, but only one for Gag and
R-5′UTR. Therefore, one would expect quantities of R-U5 or
U3–U5 to be higher than those for Gag or R-5′UTR upon
completion of reverse transcription. However, if the vDNAs are
degraded in the mutants, these ratios and 2-LTR circle levels
could change.
Kinetics of reverse transcription
The quantities of vDNA measured in wild-type, NCH23C-,
and NCH44C-mutant virus infections are presented in Figs. 1A–
C. Comparisons of reverse transcription intermediates over the
time-course revealed that the quantities and kinetics of vDNA
synthesis in the NC mutant infections were quite different from
wild-type infections after the initial 4-h harvest time. Initially,
the levels of R-U5 were very similar for all infections, taking
into account the approximate 75% reduction in genome
packaging of the NCH44C mutant virus. This would indicate
that if these mutations cause any defects in reverse transcription
initiation, they are minor. Wild-type infections proceeded withe determined by taking the mean of logarithm transformed copy numbers from 5
ts. Quantities of vDNA from (A) wild-type, (B) NCH23C, and (C) NCH44C mutant
cessary clutter, both visually and conceptually. The standard error of the mean
ted lines indicate the lower limit of reliable quantitation of proviruses, which is
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fection (Fig. 1A). In contrast, reverse transcription intermedi-
ates in the NCH23C and NCH44C mutant virus infections (Figs.
1B and C) began to decrease at 4 h postinfection. The difference
in peak times is likely due to a greater rate of degradation of the
newly synthesized vDNA during mutant infections, in agree-
ment with our previous observations (Buckman et al., 2003).
Comparison of the profiles of R-U5 over the time-course
between wild-type and NCH23C- or NCH44C-mutant viruses
reveals dramatic differences at later time-points (compare R-U5
in Figs. 1A to that in B or C). After 12 h of infection, the mutant
profiles are significantly different from wild-type: NCH23C
(P < 0.0001), NCH44C (P < 0.0001). From 12 to 72 h post-
infection, the decrease in quantities of R-U5 in the wild-type
infection is 2-fold, whereas that observed with either NC mutant
is nearly 20-fold. This again shows that the vDNA synthesized
in wild-type infections is fairly stable, while that synthesized by
the mutants is not as stable. The profiles of U3–U5, Gag, and R-
5′UTR in infections with either mutant are similar to those for
R-U5, and analyses of the profiles between wild-type and these
mutants yield identical interpretations as for the R-U5 analysis;
there are very significant differences in profiles after 12 h of
infection. These results demonstrate the negative effects of NC
mutations on vDNA stability.
Failure to see accumulation in reverse transcription products
after infection with the NCH23C or NCH44C mutants could be
due either to increased degradation of vDNA after synthesis or
to a faster rate of reverse transcription. These possibilities were
examined by investigating earlier time-points of infection by
spinoculation (O'Doherty et al., 2000) of HOS cells for 1 h, then
harvesting total cellular DNA at 1, 2, 3, and 4 h postinfection.
Spinoculation was used to boost infection so that vDNA could
be reliably quantitated. To control for plasmid contamination in
this system, we spinoculated HOS cells with identical heatFig. 2. Quantities of vDNA during early infection after spinoculation. Average quantit
(C) are shown normalized to cell equivalents and input genome quantities. Plasmid c
with each virus heat inactivated (68 °C for 20 min) and the DNA signal from the heat-i
HOS cells incubated with intact virus. Error bars represent standard deviations frominactivated and untreated virus stocks (WT, NCH23C, and
NCH44C). We then subtracted the background DNA signal
(from the HOS cells incubated with the heat-inactivated virus)
from the vDNA signal obtained from the HOS cell infections.
The most striking observation is that both NCH23C and
NCH44C had substantially higher levels of vDNA than wild-
type at the earliest time-points. At 1 h postinfection, the
earliest reverse transcription intermediate was at least 100-fold
higher in the mutant infections than in wild-type (Fig. 2A).
The late reverse transcription intermediate was almost 1000-
fold higher in the mutant infections than in wild-type at the
initial 1 h time (Fig. 2B). Quantities of 2-LTR circles were
100- to 1000-fold higher in the mutant infections than in the
wild-type infection (Fig. 2C).
Strand transfer efficiency
Both NCH23C and NCH44C have exhibited defects in minus-
and plus-strand transfers when tested in cell free assay systems
(Guo et al., 2002; Levin et al., 2005). Therefore, we examined
the quantities of the various reverse transcription intermediates
relative to one another. The ratio of quantities of U3–U5 to R-
U5 provides an estimate of the efficiency of minus-strand
transfer, while the ratio of R-5′UTR to Gag provides an
estimate of the efficiency of plus-strand transfer. The efficiency
of minus-strand transfer over the time-course of wild-type
infections is approximately 70% (Fig. 1A), while the efficiency
of plus-strand transfer over the same time-course is 70–80%
(Fig. 1A). Thus, once reverse transcription begins, it appears to
proceed to completion. Infections with NCH23C mutant showed
minus-strand transfer efficiencies that were very similar to
wild-type (compare ratios in Figs. 1B and A), but plus-strand
transfers were lower than wild-type over the first 24 h
(compare ratios in Figs. 1B and A). Prior to 24 h, theies of early (A) and late (B) reverse transcription intermediates and 2-LTR circles
ontamination from transfections was determined by spinoculation of HOS cells
nactivated virus incubations was subtracted from the vDNA signal obtained from
2 separate experiments. Symbols are presented at the bottom of the figure.
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is significantly different from wild-type at hours 4 (P = 0.044),
8 (P = 0.019), 12 (P = 0.013), and 24 (P = 0.021). The
observation that the efficiency is the same as that of wild-type
at hours 48 and 72 is most likely because the majority of
remaining vDNA at those time-points is either proviral or
circular, both of which are stable species. It is unclear why, but
minus- and plus-strand transfer efficiencies in NCH44C
infections are not reduced. They are, in fact, higher than
those of wild-type (compare ratios in Figs. 1C and A).
Kinetics of provirus formation
Provirus levels were determined using Alu-LTR real-time
quantitative PCR adapted from the method described by Butler
et al. (2001). Proviruses measured during wild-type infections
peaked at 24 h postinfection, and were 30–50% of the levels of
R-5′UTR (Fig. 1A). Thus, the efficiency of integration, defined
here by conversion of late reverse transcription products (R-5′
UTR) to provirus, appears reasonably high. Interestingly, the
peak in provirus formation occurs 12 to 18 h after the peak in
reverse transcription (Figs. 1A–C), which indicates that reverse
transcription is not the rate-limiting step of early infection.
Quantities of provirus measured in the mutant infections were at
least 100-fold lower than those from wild-type infections
(compare proviruses detected in Figs. 1A to B and C). Proviral
levels in the NCH23C or NCH44C infections peak at 24 h, a time-
point where the quantities of reverse transcription intermediates
are only about 10-fold lower thanwild-type quantities. However,
the levels of proviruses in the mutant infections are reduced
much more dramatically at 24 h compared to wild-type. This
indicates a specific block to integration, which is more signi-
ficant than any of the defects observed for reverse transcription.
This block is also evident from the differences in quantities of R-
5′UTR and proviruses (compare in Figs. 1A to B and C).
Kinetics of 2-LTR circle formation
Because it is possible that the lack of provirus formation in the
mutants was a result of a lack of substrate for integration (vDNA
with completed LTR ends), quantities of 2-LTR circles were
examined. The formation of 2-LTR circles is the result of nuclear
ligases acting upon full-length or nearly full-length vDNA (Li et
al., 2001), so reduced quantities of the linear vDNA precursors
would result in reduced quantities of the circles as well (the
primers and probe used to detect 2-LTR circles will tolerate
deletions of up to about 100 bp at the circle junctions). 2-LTR
circles peaked at 24 h postinfectionwith the wild-type virus (Fig.
1A), and at this time, quantities were approximately 10-fold
lower than quantities of R-5′UTR. Quantities of 2-LTR circles in
NCH23C infections peaked at 8–12 h postinfection, and were
about 10-fold lower than R-5′UTR (Fig. 1B). Infections with
NCH44C resulted in quantities of 2-LTR circles that peaked at
12 h postinfection, and were also about 10-fold lower than R-5′
UTR levels (Fig. 1C). Comparison of the profiles in 2-LTR
circles between infections with wild-type and NCH23C demon-
strates significant differences (P = 0.0003) after 24 h (compare 2-LTR circles in Figs. 1A and B). This is because quantities of 2-
LTR circles decrease at a significantly higher rate in NCH23C
infections than with wild-type (P < 0.0001). Profiles between
infections with wild-type and NCH44C revealed significantly
different quantities of 2-LTR circles at all time-points (P < 0.02)
(compare 2-LTR circles in Figs. 1A and C). Because 2-LTR
circle levels peak earlier in NC mutant infections, it can be
concluded that the vDNA synthesized in the mutant infections is
less stable than in wild-type infections.
IND116N mutant viruses with wild-type NC
Reverse transcription intermediate profiles from wild-type
infections, with and without a functional integrase (IN), are
significantly different (Figs. 1A and 3A, respectively). From
12 h postinfection and later, reverse transcription intermediates
decrease linearly in both infections. However, these species
decrease 3-fold faster in IND116N infections (Fig. 3A) with the
difference in slopes being highly significant (P = 0.0003).
Therefore, one may conclude that blocking integration results in
a dramatically different profile of vDNA reduction over time.
The fact that quantities in IND116N infections decrease so rapidly
relative to wild-type suggests a more rapid loss of vDNA. This
is presumably due to dilution of stable 2-LTR circles during cell
division, as well as degradation of linear vDNA species; the
reduction in vDNA levels is more rapid than would be expected
solely by dilution.
NCH23CIND116N and NCH44CIND116N mutant viruses
The profiles of reverse transcription intermediates from the
NCH23C and NCH23CIND116N or NCH44C and NCH44CIND116N
infections are quite similar (compare Figs. 1B to 3B and 1C to
3C), respectively). This is expected since the NC mutations
themselves created such a large reduction in integration,
compared to wild-type infections (Figs. 1A–C provirus
profiles). The principal difference, comparing infections with
the NC mutants alone, and with their IND116N counterparts, is
that quantities of reverse transcription intermediates with either
the NCH23C or NCH44C mutant viruses do not decrease as much
toward the end of the time-course. The decline in reverse
transcription intermediates in NCH23CIND116N mutant virus
infections (Fig. 3B) is strongly linear (P < 0.0001), decreasing
100-fold from 12–72 h. The declines in reverse transcription
intermediates in NCH23C infections are also highly significant
(P < 0.0001), but level off (significantly, P = 0.0002) at later
time-points such that quantities are reduced only 20-fold within
the 12–72 h time period (Fig. 1B). Similarly, the downward
trends for NCH44C intermediates (Fig. 1C) are highly significant
(P < 0.0001) and level off (P = 0.010) such that quantities at
72 h have decreased about 10-fold from their 12-h values. The
downward trends for NCH44CIND116N reverse transcription
intermediates (Fig. 3C) are also highly significant (both linear
and quadratic “leveling off” components with P < 0.0001), with
quantities at 72 h having decreased approximately 100-fold
from their 12-h values. It is likely that, in both the NCH23C- and
NCH44C-mutant infections, the observed leveling off represents
Fig. 3. Quantities of vDNA over a time-course of infection with IND116N. Values for each point were determined by taking the mean of logarithm transformed copy
numbers from 4 (NCH23CIND116N), or 2 (IND116N, NCH44CIND116N) separate transfection-infection experiments. Quantities of vDNA from (A) IND116N, (B)
NCH23CIND116N, and (C) NCH44CIND116N, mutant virus infections. Error values are as noted in Fig. 1. Symbols are presented at the bottom of the figure. Dotted lines
indicate the lower limit of reliable quantitation of proviruses, which is approximately 100 copies and note that provirus analysis was performed on these samples;
however none were detected, as expected.
Table 2
Summary of virus characteristics
Virus Efficiency
of reverse
transcription a
+ST
efficiency b
Integration
efficiency c
vDNA
stability d
Replication e
NCH23C 9.1% 69 ± 2.0% <0.63% 20-fold No
NCH44C 18% 119 ± 2.9% <0.65% 20-fold ±(wt reversions)
Wild
type
24% 100% 4.6% 2-fold Yes
a “Reverse transcription efficiency” is calculated by taking the ratio of
maximum quantities of R-5′UTR to maximum quantities of R-U5.
b “Plus-ST efficiency” (plus-strand transfer efficiency) is calculated by
averaging the plus-strand transfer efficiency ± the standard deviation from Fig.
1 over the first 24 h for each infection. The average was used since the values did
not change significantly for a particular virus infection over this initial period.
c “Integration efficiency” is calculated by dividing maximum quantities of
provirus by maximum quantities of R-U5 (Fig. 1).
d vDNA stability indicated by the decrease in R-5′UTR levels from 12 to 72 h
postinfection (Fig. 1).
e Replication in H9 cells, data from Gorelick et al. (1999b).
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fraction of total vDNA. It is also probable that the leveling off
in the NCH44CIND116N mutant virus infections (Fig. 3C) is due
to the persistence of circular forms, as the profile of 2-LTR
circles closely resembles those observed for the reverse trans-
cription intermediates.
2-LTR circles when integration is blocked
When integration is blocked, any vDNA that would have
been integrated will become circularized or degraded. Thus,
quantities of 2-LTR circles are much higher in infections with
IND116N compared to wild-type virus (compare 2-LTR circle
quantities between Figs. 1A and 3A). In addition, it was
observed that quantities of 2-LTR circles account for the
majority of vDNA present in IND116N infections from 24 h
postinfection and later (Fig. 3A). This was not observed with
either the NCH23CIND116N- (Fig. 3B) or NCH44CIND116N-virus
(Fig. 3C) infections. Maximal quantities of 2-LTR circles
increase 19-fold when integration is blocked in infections with
wild-type NC-containing viruses (compare Figs. 1A and 3A).
However, for viruses with either NC mutation, this maximal
ratio is significantly reduced (1.8-fold and 3.8-fold for NCH23C
and NCH44C, respectively) compared to that observed in wild-
type infections (NCH23C P = 0.0036, NCH44C P = 0.035;
compare Figs. 1B and 3B, 1C and 3C).
Efficiencies of infection processes
Comparison of the relative efficiencies of reverse transcrip-
tion and integration with these NC mutant or wild-type virus
infections is presented in Table 2. The efficiency of reverse
transcription is calculated by taking the ratio of maximumquantities of R-5′UTR to maximum quantities of R-U5.
Infections with the NCH23C mutant virus show at least a 2-
fold lower efficiency than wild-type. The efficiency of reverse
transcription is only marginally lower for NCH44C mutant virus
infections compared to wild-type (less than 2-fold). The
efficiencies of integration, calculated by taking the ratio of
maximum quantities of provirus to maximum quantities of R-
U5, with either NCH23C or NCH44C mutant virus infections, are
at least 10-fold lower than wild-type.
Discussion
The in-depth kinetic studies presented here showed that,
during HIV-1 infection, both the NCH23C and NCH44C mutations
47J.A. Thomas et al. / Virology 353 (2006) 41–51caused severe defects in integration, but less severe defects in
reverse transcription. It should be noted that even minor
alterations at the ends of the linear vDNA would make the
vDNA an unsuitable substrate for integration (Leavitt et al.,
1996), so that reverse transcription could still be quite efficient
but nonetheless impair integration. This aspect would not be
detected by the analyses performed in these studies. However, it
was observed in previous work from this laboratory that there
were defects in CA-dinucleotide removal in NC-mutant viral
infections (Buckman et al., 2003), a process that is required for
efficient integration (Ellison and Brown, 1994), and this would
also account for some of the observed integration defects in the
present study. The results of these kinetic studies permit one to
draw some general conclusions regarding the contributions of
the amino- and carboxyl-terminal zinc-fingers in integration,
vDNA stability, and reverse transcription during viral infection.
First, both zinc-fingers are necessary for efficient integration.
Infection with either the NCH23C or NCH44C mutant viruses
resulted in substantial decreases in provirus formation (i.e.,
integration efficiency), compared to wild-type (Table 2). This
defect is much larger than what one would predict from the
observed defects in reverse transcription (Table 2). Although
reduced stability of vDNA may be involved, it should be noted
that the rate at which reverse transcription intermediates
decrease with either of the NC mutant infections is similar to
what was observed with the IND116N mutant. However, toward
the end of the time-course, quantities of these vDNA species
with the NC mutants begin to level off, presumably due to a low
level of integration (compare reverse transcription intermediates
in Figs. 1B and C to 3A). This leveling off is important in that
the reduced stability is similar to what was observed when only
integration was blocked at times after 12 h. Thus, the
predominant phenotype of these two NC mutants matches, to
a large extent, the phenotype of an IN mutant that specifically
blocks the integration reaction (Engelman et al., 1995).
Previously our laboratory noted that the NCH23C mutant virus
was phenotypically quite similar to the IND116N mutant virus in
viral protein expression, gRNA packaging, infectivity in a
single-cycle β-gal reporter assays, and replication-defective in
long-term H9 infectivity assays (Gorelick et al., 1999b).
Second, both zinc-fingers are important for the stability of
vDNA. Infections with either NC mutant result in quantities of
vDNA beginning to decrease from the earliest time-point
examined, and the rate at which reverse transcription inter-
mediates decrease is much faster for these two zinc-finger
mutants than for wild-type (Fig. 1 and Table 2). Although the
decrease in quantities of vDNA is similar to what was observed
in IND116N mutant virus infections at later times, there is no
buildup at earlier time-points of infection. The lack of any
buildup in reverse transcription intermediates indicates insta-
bility of these species beyond what was observed with the
IND116N mutant alone. Further support for vDNA instability is
also provided by the observation that when integration is
specifically blocked (by addition of the IND116N mutation) in
either NC mutant virus, the quantities of 2-LTR circles
measured are 1–2 logs reduced when compared to the levels
observed in the IND116N mutant infections alone over the entiretime-course (Figs. 3A–C). In addition, the levels of circular
species in NC-mutant infections, with or without functional IN,
are significantly lower than for the wild-type virus (Figs. 1 and
3). These results agree with previous work demonstrating
protection of vDNA by NC from cell-free experiments
(Lapadat-Tapolsky et al., 1993; Tanchou et al., 1995) and in
infections as well (Berthoux et al., 1997; Buckman et al., 2003).
Third, alteration of the amino-terminal zinc-finger decreases
the efficiency of plus-strand transfer (Table 2), but not minus-
strand transfer. Interestingly, the carboxyl-terminal zinc-finger
mutant has no discernible affect on strand transfer reactions
during infections (Fig. 1C). This result is in contrast to in vitro
strand transfer studies, where both mutations cause decreased
efficiencies of minus-strand (Guo et al., 2002) and plus-strand
transfers (Levin et al., 2005) in systems using recombinant
mutant NC proteins. Important differences between in vitro
assay systems and strand transfers that occur during infections
are (i) the relative concentration of the NC protein and (ii) the
presence of additional viral and cellular components. The
concentration of NC present in the virion core is much higher
than what can realistically be achieved in vitro, so minor
changes in nucleic acid binding affinity would be observed at
the lower NC concentrations used in vitro but not in vivo. These
results also show a small decrease in the overall efficiency of
reverse transcription for NCH23C (>2-fold) and NCH44C (<2-
fold) mutant viruses, compared to wild-type (Table 2).
In contrast to the minor changes in the overall efficiency of
reverse transcription, there is a substantial increase in the initial
rates of reverse transcription in both the NCH23C or NCH44C
mutants compared to wild-type. It has been reported that reverse
transcription can begin within HIV-1 particles (Lori et al., 1992;
Trono, 1992; Zhang et al., 1993, 1994) and early vDNA
products were estimated to be 1/100th to 1/10,000th that of
measured RNA templates. It appears that these NC mutations
permit even higher levels of intravirion reverse transcription
compared to wild-type (e.g., 10–100-fold greater than wild
type). Conversely, these mutations may permit reverse tran-
scription to reach its maxima faster in these mutant virus
infections, once it commences. Presumably this would be
because the core structure is less compacted. We have attempted
to quantitate vDNA contained in the virus particles but plasmid
contamination from transfection-generated virus is far too great
to enable reliable analysis; the residual CaPO4-DNA precipitate
appears to be DNase resistant.
Interestingly, when integration was blocked in infections
with either NC mutant, quantities of 2-LTR circles increase only
slightly (compare Figs. 1 and 3). Two conclusions may be
drawn from this observation. First, relatively little integration is
occurring with either of the NC mutant virus infections, which
is supported by the small quantity of proviruses detected (Figs.
1B and C). If integration were to occur at levels close to wild-
type, blocking integration would result in a considerable
increase in 2-LTR circles (compare Figs. 1A and 3A). Second,
the majority of vDNA appears to be degraded in the mutant
infections, before it reaches the point at which it can be
converted to 2-LTR circles or the ligated species that is formed
cannot be detected with this assay due to extensive degradation
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the nuclear ligases that catalyze 2-LTR circle formation could
produce increased numbers of targets.
These new results support, and substantially extend the
conclusions from our previous reports (Buckman et al., 2003;
Gorelick et al., 1999b). The integration defect observed
previously was directly confirmed using Alu-LTR real-time
quantitative PCR, and the instability of vDNAwas also clearly
observed in this study. In addition, kinetic analyses demon-
strated a strand transfer defect, which was only suggested from
our previous work (Buckman et al., 2003). These results also
assist in explaining the relative differences in the ability of
NCH23C and NCH44C mutant viruses to replicate (Table 2;
Gorelick et al., 1999b). Our current findings suggest that one
reason NCH44C can revert to wild-type is because this mutation
has less of an effect on reverse transcription and integration
(Table 2); sufficient full-length vDNA can be synthesized and
integrated to allow for the occasional reversion. Because
NCH23C is less efficient at reverse transcription and integration
(Table 2), the threshold level of integration is not reached and
the occasional reversions are rare or nonexistent. The difference
in reverse transcription efficiencies between these two NC
mutants is very small, but this difference may be enough to
enable NCH44C mutant virus to replicate at very low levels until
reversion, while NCH23C mutant virus cannot. Although there is
some debate as to whether NC is actually present in
preintegration complexes based on a failure to detect it in
such complexes isolated from cells (Farnet and Bushman, 1997;
Gallay et al., 1995; Nermut and Fassati, 2003), these data
provide strong support for a direct role of NC in the integration
step of infection.
It is possible that these NC mutations interfere with nuclear
entry and because the vDNA may be excluded from the nucleus
longer than vDNA in the wild-type case, it is degraded. The
evidence against this is that the relative efficiency of formation
of 2-LTR circles is similar to wild-type (compare Figs. 1A to B
and C) and that 2-LTR circles are detected in large quantities
very early after infection (Fig. 2C). The HOS cells used for our
analysis divide approximately every 23 h, so targeted nuclear
entry could be bypassed. If there are defects in nuclear entry,
they are minor and cannot be measured reliably using our assay
systems. It is important to note that the NCH23C and NCH44C
mutants are very replication defective in H9 infectivity assays,
and in this system H9 cells are also dividing frequently
(Gorelick et al., 1999b). Therefore, there is a replication defect
even when a substantial portion of preintegration complexes can
diffuse into the nucleus during mitosis.
In conclusion, both the NCH23C and NCH44C mutations
cause progressively larger defects during early infection
events. Ultimately, however, the principal reason for the
replication-defective phenotypes of these two mutants is
impairment of integration. Although the mechanism of this
impairment is not fully understood, it may be the result of
aberrant preintegration complex formation resulting in de-
creased efficiency of end processing by IN (Buckman et al.,
2003). Regardless of the reason, this study highlights the
critical role played by NC throughout the processes of earlyinfection, including reverse transcription, protection of vDNA,
and integration.
Materials and methods
Plasmid constructs
Construction of the NCH23C, NCH44C, and RTD185K/D186L
mutants in pNL4-3 GenBank accession numbers AF324493 and
M19921 (Adachi et al., 1986) were described previously
(Gorelick et al., 1999b). The IND116N mutant in pNL4-3 was
described by Engelman et al. (1995). Construction of the
combination NCH23CIND116N was reported by Buckman et al.
(2003), and the NCH44CIND116N mutant used in this work was
constructed in the same fashion. A frameshift mutation was
introduced into env of all of the proviral clones (Ott et al., 1999),
which prevented expression of HIV-1 Env proteins. The
plasmid pHCMV-g, which expresses VSV-G (Burns et al.,
1993), was a generous gift from Jane Burns (University of
California, San Diego). DNA manipulations were performed
using standard molecular biological reagents and procedures.
All mutations were verified by nucleic acid sequencing.
Cell culture, transfections, infections, and total cellular DNA
isolation
293T cells (Gorelick et al., 1996) and HOS (human
osteosarcoma) cells (Julias et al., 2001; McAllister et al.,
1971) were maintained as described previously (Gorelick et al.,
1999b; Julias et al., 2001). Pseudotyped virus generated from
293T cells by calcium phosphate transfection, and infection of
HOS cells with subsequent isolation of total cellular DNAwere
performed as described by Julias et al. (2001), except that 2 μg/
mL of hexadimethrine bromide (Polybrene; Sigma-Aldrich, St.
Louis, MO) was added to culture fluids prior to application to
HOS cells. Exogenous template RT assays were performed as
described in Gorelick et al. (1990). For examining infection
times earlier than 4 h, HOS cells were spinoculated with mutant
and wild-type viruses (Fig. 2) to increase infectious titers based
on a modified version of the reported system of O'Doherty et al.
(2000). 2 × 105 HOS cells were incubated with virus at 1900 × g
for 1 h at room temperature. Heat inactivation of viruses was
conducted by incubating mutant or wild-type virus stocks at
68 °C for 20 min. The heat inactivated stocks were applied in
parallel with unheated stocks and used as a means of
determining contaminating plasmid DNA levels, so accurate
vDNA quantities could be determined from the infections.
Isolation of viral RNA
Virus from cell culture supernatants was pelleted at
100,000 × g using a Beckman TLA100.3 rotor (Beckman-
Coulter, Fullerton, CA) at 4 °C for 30 min. Pellets were
resuspended in lysing buffer (50 mM Tris, 10 mM EDTA,
100 mM NaCl, pH 7.4, 1% (w/v) SDS, 50 μg/mL yeast tRNA
(Invitrogen, Carlsbad, CA), and 100 μg Proteinase K (Invitro-
gen) for 3–5 h at 37 °C. Samples were extracted twice using
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Invitrogen) and precipitated with 70% (vol./vol.) ethanol and
0.3 M sodium acetate, pH 5.3. Samples were centrifuged at
21,000 × g at 4 °C to collect nucleic acids, dried, and then treated
with 20 U of RQ1 RNase-free DNase (Promega, Madison, WI)
in a total volume of 200 μL for 1 h, according to the man-
ufacturer's instructions. The reaction was stopped by adding
200 μL of 4 M guanidine isothiocyanate, the nucleic acids were
precipitated with 40 μL 3 MNaOAc, pH 5.3, 5 μL of 25 mg/mL
yeast tRNA, and 1026 μL ethanol at−20 °C overnight. The RNA
precipitate was resuspended in diethylpyrocarbonate-treated
water with 0.1 mM DTT (Promega) and 1 U/μL RNaseOUT
(Invitrogen).
DNA and RNA standards
Plasmids pRB1008 (for reverse transcription intermediates)
and pJB1041 (for total 2-LTR circles), used for standard
curves in real-time quantitative PCR have been described
(Buckman et al., 2003). The standard template for CCR5, 96-
2A hCCR5 (used for quantitation of cellular DNA equiva-
lents), was kindly provided by Srinivas Mummidi (Depart-
ment of Medicine, VA Center for HIV and AIDS, University
of Texas Health Science Center at San Antonio). CCR5,
located on chromosome 3 in human cells (Samson et al.,
1996), was used to estimate cell equivalents for quantifying
DNA recoveries. This plasmid (96-2A hCCR5) was digested
with XbaI (New England Biolabs, Beverly, MA) to provide a
linear DNA standard.
The standard template for quantitation of viral RNA was
constructed by cutting pNL4-3 with BssHII, the ends were filled
in with Klenow, and the resulting linear DNAwas cut with ApaI.
The 1299 bp blunt/ApaI fragment (containing HIV-1 gag) was
isolated and cloned into the EcoRV/ApaI sites of pBluescript KS
(+) (Stratagene, La Jolla, CA). The resulting plasmid, pRB1334,
was cut with KpnI to generate linear DNA, which was used as a
template with the RiboMAX Large Scale RNA Production
System (Promega) according to the manufacturer's instructions.
Using the Sigma Spin Column 30 (Sigma-Aldrich), unincorpo-
rated nucleotides were removed. RNA transcripts were quanti-
tated by absorbance at 260 nm, then diluted to 106 copies/μL and
stored at −70 °C in single-use aliquots.
Real-time quantitative PCR and reverse transcriptase-PCR
(RT-PCR)
Primers were purchased from Invitrogen, and probes from
Biosource International (Camarillo, CA). Transfections with the
proviral plasmid encoding the RTD185K/D186L mutant virus were
performed for each infection experiment to assess the levels of
contaminating carryover plasmid DNA. Real-time quantitative
PCR protocols, primers, and probes used to detect specific DNA
products have been described by Buckman et al. (2003). The
PCR product sizes are: 159 base-pairs (R-U5), 211 base-pairs
(U3–U5), 156 base-pairs (Gag), 125 base-pairs (R-5′UTR), and
249 base-pairs for full-length 2-LTR junction fragments (note
that the TOT primer/probe set, described in Buckman et al.(2003) was used in this study). For CCR5 quantitation, the
primers are CCR5-For (5′-CCAGAAGAGC TGAGACATCC
G-3′), CCR5-Rev (5′-GCCAAGCAGC TGAGAGGTTA CT-
3′), and the probe is P-CCR5-01 (5′-FAM-TCCCCTACAA
GAAACTCTCC CCGG-TAMRA-3′). This PCR product is 70
base-pairs in length. The reactant concentrations for CCR5
detection are the same as described in Buckman et al. (2003)
and the thermocycler conditions were: 95 °C for 10 min, then 45
cycles of 95 °C for 15 s, 55 °C for 30 s, and 60 °C for 30 s.
RT-PCR was carried out as a two-step protocol essentially as
described by Cline et al. (2005) with the following change.
After synthesis of the cDNA, 20 μL of the PCR master mix and
thermocycler conditions for the detection of HIV-1 gag
(Buckman et al., 2003) was used instead of that for SIV gag.
Alu-LTR PCR was adapted from Butler et al. (2001), with
the following changes. The forward primer (MH535) concen-
tration was reduced to 50 nM per reaction, the reverse primer
(SB704) concentration was increased to 900 nM per reaction,
and the probe used was P-HUS-SS1 from Buckman et al.
(2003). The PCR products will be of variable length depending
on the distance between the integration site and the Alu element
(up to 5 kb) (Butler et al., 2001). The thermocycler profile
employed was: 95 °C for 10 min followed by 45 cycles of 95 °C
for 15 s, 60 °C for 1 min, 72 °C for 1 min. The integration
standard cell line was generated by transducing HOS cells with
the pLenti6/UbC/V5-DEST Gateway Vector Kit (Invitrogen)
according to the manufacturer's instructions. Transduced cells
were selected in the presence of 8 μg/mL Blasticidin
(Invitrogen) and passed for at least 8 rounds to reduce
unintegrated vDNA species to below detectable levels (Butler
et al., 2001). Genomic DNAwas isolated as described (Strauss,
2005), sheared by passing through a 20 gauge needle to make
volume measurements more accurate, and proviral equivalents
of the standard DNA were determined by measuring the late
reverse transcript R-5′UTR as described in Butler et al. (2001).
Copy numbers determined from real-time quantitative PCR
experiments were adjusted for cell equivalents (using CCR5)
and input virus (RT activity; Gorelick et al., 1990), with care
given to preserve the magnitude of signal actually measured.
Absolute copy numbers varied between experiments due to
differences in infectious titer (because of transfection efficien-
cy), and exact numbers of cells infected and recovered. Intra-
assay variation is small (less than 5%).
Statistical analysis
Data in this study were analyzed using repeated measures
analysis of variance (ANOVA), analysis of covariance
(ANCOVA), linear hierarchical mixed-effects regression mod-
els, simple and advanced graphical techniques, and post hoc
tests (Littell, 1996; Milliken and Johnson, 1992; Pinheiro and
Bates, 2000; Richardson and Overbaugh, 2005). Comparisons
both among specific virus infections across the time dimension
as well as within mutant or wild-type infections at discrete steps
(e.g., after minus-strand strong-stop synthesis [R-U5], minus-
strand transfer [U3–U5], etc.) were performed on the (common,
i.e., base 10) logarithms of the adjusted copy numbers (Figs. 1
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efficiencies of minus-strand and plus-strand transfers were
performed on percentages (ratios) of either U3–U5 to R-U5 or
plus-strand transfer (R-5′UTR) to Gag reverse transcripts (Gag)
of the raw adjusted copy numbers. Alternative within-
experiment correlation structures (e.g., autoregressive order 1
autocorrelation) and covariance structures were routinely fit to
data; assumptions regarding homogeneity of variance and
covariance were examined and assessed in the determination of
the best-fitting models. Pairwise a posteriori comparisons
among species at individual time-points were performed with
standard post hoc tests (e.g., Tukey's test) and follow-up t tests.
Interpretations of results from follow-up t tests were consistent
with those obtained from global analyses and from standard
post hoc tests. Hence, for simplicity, we report probability (P)
values obtained from the follow-up t tests at specific time-
points. All tests were two-sided; probability values less than
0.05 were considered significant.
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